FDA clears Nuvation's first product Ibtrozi, for lung cancer Nuvation is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment for ROS1-positive lung cancer.

#NuvationBio is set to launch its first commercial product after the FDA approved its ROS1 inhibitor #Ibtrozi as a treatment for ROS1-positive non-small cell lung cancer (#NSCLC).

pharmaphorum.com/news/fda-cle...

Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?  Yahoo Finance

Click Subscribe #HealthcareStocks #NuvationBio #StockMarket #Investing #DavidEinhorn